Quantcast

Biotech enters securitization jungle

While only one biotechnology-patent securitization deal has been completed so far, two Boston-based individuals have proposed a plan to make the process of securitizing these assets simpler.

Pat Trombly and Ronald Douglas, who each have tax backgrounds from big-five accounting firms, have devised a way to use "check-the-box" tax...

To continue reading, log in, register or subscribe below.Calendars are available to registered users of The Bond Buyer web site.
Please log in below with the credentials you established at the time of your subscription or when you set up a free trial. If you have never set up an account with The Bond Buyer, please click the "Free trial" link below to set up your account.

Already a subscriber? Log in here.

Please note you must now log in with your email address and password.

 

Upcoming Events

Already a subscriber? Log in here
Please note you must now log in with your email address and password.